Wednesday 26 November 2014

In the pipeline – streamlined InterPro production


You may have noticed that InterPro has had fewer releases than usual this year. It is not that we haven’t been working as hard as ever, integrating member database signatures into InterPro entries and adding Gene Ontology terms - we have! But a number of things have been going on behind the scenes, which we thought you might be interested in knowing about.

Sequence growth 
InterPro release 1.0, back in 2000, was built using a version of Swiss-Prot/TrEMBL that contained just over 300 thousand sequences. Our current InterPro release (49.0) is built using over 77 million Swiss-Prot/TrEMBL sequences. That is a massive amount of sequence growth - and even more remarkable is the fact that almost half of these sequences have been added in the last year.

A new InterPro production pipeline
As you might imagine, processing this number of sequences can cause all kinds of problems for computational pipelines that were developed when sequence data volumes were orders of magnitudes smaller. To make sure that we can handle the kind of data volume growth we have been seeing - and expect to see in the future - we have been busy rebuilding our production pipeline. The new system is built entirely on InterProScan, which, for a variety of complicated historical reasons, the previous version was not. This change helps streamline the production process, removes a number of bottlenecks, and generally makes many things associated with data production a lot less complicated.

Further pipeline developments and a new data centre 
To put these changes in place, we have had to focus a lot of our efforts on pipeline development, with knock-on effects on our release schedule. As a consequence, while we have maintained our usual rate of database integrations, these have been squeezed into slightly fewer InterPro releases. And, as a further complication, we have also recently moved all of our data (in the form of hard drives on the back of a truck - no, really!) to a new data centre, as part of EMBL-EBI’s consolidation of its Web infrastructure. This has impacted our release schedule further still. However, we believe that we are now much better placed to calculate and provide match data for our users. We think we are also better prepared for future data production challenges - as the number of protein sequences hits 100 million, and beyond.

Alex Mitchell
on behalf of the InterPro team

Thursday 6 November 2014

Protein focus: Don’t blame the cat - the toxoplasmosis effect


By Amaia Sangrador and Alex Mitchell





You may have heard about toxoplasmosis, or read about it in a newspaper or magazine. Toxoplasmosis is a condition caused by the protozoan Toxoplasma gondii, an intracellular parasite that infects a wide variety of warm-blooded animals, including humans. T. gondii has attracted the attention of both the scientific and lay communities, and with good reason. It is one of the most successful parasites, infecting over one third of the human population, with rates varying depending upon geographical location1.

Acute toxoplasmosis usually only poses a risk for immunocompromised individuals or pregnant women. However, residual parasites persist lifelong after the acute phase. Though this latent form of the infection was thought to be asymptomatic, a growing body of evidence suggests that this is not the case2. And the long term effects of infection with T. gondii seem related to the most fascinating aspect of this parasite: its ability to modify host behaviour.

Members of the cat family (Felidae) are the only definitive hosts of T. gondii within which the parasite undergoes sexual reproduction. This culminates with the production of oocysts that are shed in the cat’s faeces. Within intermediate hosts (cat’s natural prey, such as rodents and birds)  and other incidental intermediate hosts (such as humans and domestic livestock), the parasite undergoes asexual reproduction, producing bradyzoites that can encyst in the brain and other tissues, where they remain potentially for the host’s lifetime3. Infection can occur following ingestion of oocysts via contaminated soil or water, or ingestion of tissue cysts through raw/undercooked infected meat.


Fig 1. Life-cycle of the parasite Toxoplasma gondii. Sexual reproduction can only be accomplished in felines, and results in the production of sporozoites-containing oocysts that are shed for a limited period. Within intermediate hosts, the parasite undergoes asexual reproduction, producing rapidly dividing tachyzoites - cleared by the immune system - and slowly dividing bradyzoites that can persist as tissue cysts.

Figure by Sebastien Pesseat  



Given that sexual reproduction of T. gondii can be accomplished only in felines, the parasite needs to secure eventual transmission from its intermediate host reservoir, primarily rodents, to its feline definitive host. T. gondii deals with this by manipulating the intermediate host’s behaviour. Toxoplasma infection draws rats to cat odours, increasing activity in limbic regions related to sexual attraction when exposed to cat urine, turning what should be a fear response into a ‘fatal feline attraction4'. The intriguing question is: how does the parasite manage to alter the host behaviour? 



Figure by Sebastien Pesseat


One line of evidence suggests that the parasite alters neurotransmitter signals in the brain through increased dopamine levels, supported by studies showing that parasite-induced behavioural changes can be disrupted with dopamine antagonists5,6. The genome of T. gondii contains two genes encoding an enzyme capable of producing L-DOPA (3,4-dihydroxy-L-phenylalanine), the precursor to dopamine7. One of the genes, TgAaaH1, is constitutively expressed, whilst the other gene, TgAaaH2, is induced during the cyst stages. They encode dual activity amino acid hydrolases, bi-functional enzymes that catabolyse both the amino acids phenylalanine and tyrosine. Thus, they can generate tyrosine from phenylalanine and then use tyrosine to produce L-DOPA. These steps are catalysed in Metazoa by phenylalanine hydroxylase and tyrosine hydroxylase, respectively.
Fig 2. Dopamine biosynthesis pathway


In InterPro, these dual activity amino acid hydrolases are classified as belonging to the aromatic amino acid hydroxylase family (IPR001273). They consist of two domains: an N-terminal ACT domain (IPR002912), and a C-terminal aromatic amino acid hydroxylase domain (IPR019774). The C-terminal domain is responsible for catalysis and the N-terminal domain determines the substrate specificity. You can read more about these proteins and domains on the InterPro website.

Fig 3. InterPro view for aromatic amino acid hydroxylase 1 from T. gondii 
(UniProt protein B2L7T1), the product of gene TgAaaH1.




But if T. gondii can alter the behaviour of cats’ natural prey, what happens when secondary hosts like humans are infected? Altering host behaviour in ‘inappropriate’ hosts seems to be an unnecessary but unavoidable consequence of the parasite’s strategy8. Indeed, studies have revealed a range of subtle behavioural alterations associated with T. gondii infection in humans, many of which may be comparable to those observed in infected rodents – such as increased activity and decreased reaction times. Studies indicate that some of these changes can be sex-specific, as infection has been reported to increase testosterone levels in men, but decrease its levels in women. Consequently, infected men have tendency to disregard rules and are more suspicious and jealous. In women, the shift in these two factors is opposite; they are more warm-hearted, extrovert and easy-going9. More worrying is the link that may exist between infection and psychiatric conditions, such as schizophrenia, in some individuals. This association is supported by several observations, starting with the prevalence of toxoplasmosis in schizophrenic patients10. Furthermore, antipsychotic drugs, known to be effective in schizophrenia, also inhibit T. gondii11. Meanwhile, raised or disrupted dopamine levels have been reported in both rodent and human T. gondii infection and within human patients with schizophrenia12,13

And when you think it cannot get more bizarre, well, it does. Some studies show Toxoplasma’s modification of behaviour persists even after all parasites and cysts have been cleared14. This would contradict the cyst-centric theories, which explain the modification of host behaviour as a result of the parasite’s cysts actively modulating dopamine production or affecting neuronal activity15According to a recent study, an explanation for the persistence of the effects induced by the parasite could reside in its ability to induce epigenetic changes in the host. A change in the  methylation state of the arginine vasopressin promoter has been observed in infected animals, resulting in increased expression of this hormone, and affecting a testosterone-responsive area of the brain known for its role in male sexual behaviour16.  If T. gondii is capable on inducing epigenetic changes, we should consider whether other parasites and pathogens may use similar strategies.

This brings us to an existential question where philosophy and science meet: what is free will if our behaviour can be manipulated? Perhaps, as the philosopher Jose Ortega y Gasset said, we are us and our circumstances. So don’t worry about what might have been. As a future precaution, remember that most people get infected through ingestion or contact with undercooked meat, so make sure that you wash your hands and utensils after handling raw meat. And don’t blame the cat for your behaviour!

Friend or dinner?
Picture from MorgueFile.com, modified by Hsin-Yu Chang


References

1. Flegr J, Prandota J, Sovičková M, Israili ZH. Toxoplasmosis - a global threat. Correlation of latent for the futuretoxoplasmosis with specific disease burden in a set of 88 countries. PLoS One. 9(3):e90203. 2014. [PMID: 24662942]

2. Bhadra R, Cobb DA, Weiss LM, Khan IA. Psychiatric disorders in toxoplasma seropositive patients--the CD8 connection. Schizophr Bull. 39(3):485-9. 2013. [PMID: 23427221]

3. Webster JP, Kaushik M, Bristow GC, McConkey GA. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol. 216(Pt 1):99-112. 2013. [PMID: 23225872]

4. House PK, Vyas A, Sapolsky R. Predator cat odors activate sexual arousal pathways in brains of Toxoplasma gondii infected rats. PLoS One. 6(8):e23277. 2011. [PMID: 21858053]

5. Prandovszky E, Gaskell E, Martin H, Dubey JP, Webster JP, McConkey GA. The neurotropic parasite Toxoplasma gondii increases dopamine metabolism. PLoS One. 6(9):e23866. 2011. [PMID: 21957440]

6. Webster JP, Lamberton PH, Donnelly CA, Torrey EF. Parasites as causative agents of human affective disorders? The impact of anti-psychotic, mood-stabilizer and anti-parasite medication on Toxoplasma gondii's ability to alter host behaviour. Proc Biol Sci. 273(1589):1023-30. 2006. [PMID: 16627289]

7. Gaskell EA, Smith JE, Pinney JW, Westhead DR, McConkey GA. A unique dual activity amino acid hydroxylase in Toxoplasma gondii. PLoS One. 4(3):e4801. 2014. [PMID: 19277211]

8. Webster JP, Kaushik M, Bristow GC, McConkey GA. Toxoplasma gondii infection, from predation to schizophrenia: can animal behaviour help us understand human behaviour? J Exp Biol. 216:99-112. 2013. [PMID: 23225872]

9. Flegr J. Influence of latent Toxoplasma infection on human personality, physiology and morphology: pros and cons of the Toxoplasma-human model in studying the manipulation hypothesis. J Exp Biol. 216:127-33. 2013. [PMID: 23225875]

10. Torrey EF, Bartko JJ, Lun ZR, Yolken RH. Antibodies to Toxoplasma gondii in patients with schizophrenia: a meta-analysis. Schizophr Bull. 33(3):729-36. 2007. [PMID: 17085743]

11. Jones-Brando L, Torrey EF, Yolken R. Drugs used in the treatment of schizophrenia and bipolar disorder inhibit the replication of Toxoplasma gondii. Schizophr Res. 62(3):237-44. 2003. [PMID: 12837520]

12. Howes OD, Kapur S. The dopamine hypothesis of schizophrenia: version III--the final common pathway. Schizophr Bull. 35(3):549-62. 2009. [PMID: 19325164]

13. Flegr J. How and why Toxoplasma makes us crazy. Trends Parasitol. 29(4):156-63. 2013. [PMID: 23433494]

14. Ingram WM, Goodrich LM, Robey EA, Eisen MB. Mice infected with low-virulence strains of Toxoplasma gondii lose their innate aversion to cat urine, even after extensive parasite clearance. PLoS One. 8(9):e75246. 2013. [PMID: 24058668]

15. McConkey GA, Martin HL, Bristow GC, Webster JP. Toxoplasma gondii infection and behaviour - location, location, location? J Exp Biol. 216(Pt 1):113-9. 2013. [PMID: 23225873]

16. Hari Dass SA, Vyas A. Toxoplasma gondii infection reduces predator aversion in rats through epigenetic modulation in the host medial amygdala. Mol Ecol. 2014. [PMID: 25142402]